Abstract: MDD adolescents with NSSI showed abnormal changes in several microstate parameters when receiving negative emotional stimuli, and compared to those not receiving rTMS treatment, MDD adolescents with NSSI treated with rTMS showed more significant improvements in depressive symptoms and NSSI performance, as well as improvements in EEG microstate abnormalities.
Introduction
Non-suicidal self-injury (NSSI) is a critical public health concern, particularly among adolescents, where it serves as a significant predictor for future suicide attempts. While NSSI is frequently associated with Major Depressive Disorder (MDD), the real-time neurobiological mechanisms—specifically how the brain transitions between functional states in milliseconds—remain poorly understood. This study utilizes EEG microstate analysis to identify potential biomarkers for NSSI and evaluates the efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) in modulating these brain dynamics.
Methodology
The study involved 138 participants aged 12–17, categorized into three groups: MDD with NSSI (n=66), MDD-only (n=52), and healthy controls (n=20). The experimental design included a cross-sectional comparison and a longitudinal treatment phase.
The Negative Emotional Stimuli Task
Participants were exposed to facial images from the Chinese Facial Affective Picture System (CFAPS), comparing neutral and negative emotional triggers while 64-channel EEG data was recorded. The task was designed to trigger the emotional dysregulation often seen in NSSI populations.
rTMS Intervention
The MDD+NSSI group was divided into two treatment arms for eight weeks: a medication-only group (SSRIs) and a combined medication plus rTMS group. The rTMS protocol involved 10Hz stimulation targeting the left dorsolateral prefrontal cortex (DLPFC), a region critical for executive control and emotional regulation.
Results
NSSI-Specific Microstate Signatures
Microstate analysis revealed that adolescents with NSSI exhibit distinct abnormalities in Microstates (MS) 3, 4, and 6, particularly when processing negative emotions. These participants showed increased duration and coverage of MS 3, suggesting a "stuck" state during specific phases of emotional processing. These abnormalities were significantly more pronounced during exposure to negative stimuli compared to neutral ones, reinforcing the theory that NSSI is a maladaptive response to acute emotional distress.
Clinical and Neurophysiological Impact of rTMS
The combination of rTMS and medication led to superior clinical outcomes compared to medication alone. Following the 8-week intervention, scores on the Hamilton Depression Scale (8.38 vs. 12.94) and the Ottawa Self-Injury Scale (0.24 vs. 0.87) were significantly lower in the rTMS group.
Beyond clinical scores, rTMS uniquely modulated the spatiotemporal dynamics of the brain. While both treatments influenced MS 3 and 6, only the rTMS group showed significant changes in MS 1, 2, and 4. Specifically, rTMS decreased MS 1 duration and MS 4 coverage while increasing MS 2 duration and coverage. This suggests that rTMS acts as a "spatiotemporal harmonizer," modulating specific neural circuits related to cognitive executive processes and early attention that medication alone does not reach.
Discussion and Limitations
The findings suggest that microstate analysis can provide objective biomarkers for NSSI and that rTMS is an effective adjunct therapy for rebalancing brain dynamics. However, the study notes limitations, including a relatively small longitudinal sample size due to external disruptions and the need for more precise targeting using fMRI-guided neuronavigation in future research. Furthermore, while microstate changes were evident, the lack of a direct linear correlation with clinical score improvements suggests a complex relationship between brain dynamics and behavioral outcomes.
Summary updated